Ειδήσεις: EQUITIES RESEARCH | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

29/03 11:52 defenseworld.net

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Average Rating of “Moderate Buy” by Analysts

Damora Therapeutics DMRA stock rating moderate buy price target equities research

19/03 08:14 defenseworld.net

St. James’s Place plc (LON:STJ) Given Consensus Rating of “Moderate Buy” by Brokerages

St. James’s Place Moderate Buy analyst ratings price target RBC Citigroup

16/03 07:28 defenseworld.net

Pharvaris N.V. (NASDAQ:PHVS) Receives $41.70 Consensus Target Price from Brokerages

Pharvaris PHVS brokerages buy rating target price equities research

15/03 08:10 defenseworld.net

B. Riley Financial Increases Oncology Institute (NASDAQ:TOI) Price Target to $8.00

B. Riley Financial Oncology Institute price target buy rating NASDAQ:TOI equities research

15/03 08:10 defenseworld.net

B. Riley Financial Increases Oncology Institute (NASDAQ:TOI) Price Target to $8.00

B. Riley Financial Oncology Institute price target buy rating NASDAQ:TOI equities research

Loading...